Akribion Genomics

Zwingenberg, Germany

Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.

$8.3M raised

Feb 2025

Seed

Biotechnology Health Care Oncology

Top Investors

HTGF (High-Tech Gruenderfonds)Carma FundRV InvestHessen Kapital IBruker Invest

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Akribion Genomics

How much funding has Akribion Genomics raised?

Akribion Genomics has raised $8.3M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Akribion Genomics's investors?

Akribion Genomics's investors include HTGF (High-Tech Gruenderfonds), Carma Fund, RV Invest, Hessen Kapital I, Bruker Invest.

Where is Akribion Genomics headquartered?

Akribion Genomics is headquartered in Zwingenberg, Germany.

What does Akribion Genomics do?

Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.

What stage is Akribion Genomics at?

Akribion Genomics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2025.

MLA

"Akribion Genomics — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/akribion-genomics. Accessed June 17, 2026.

APA

VCBacked. (2025). Akribion Genomics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/akribion-genomics

Wikipedia (cite web)

{{cite web |title=Akribion Genomics — Funding & Investors |url=https://www.vcbacked.co/company/akribion-genomics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2025.

Similar Companies in Biotechnology